| Studies in myasthenia gravis. Pyridostigmine-C14 metabolism after thymectomy. | |
| | |
MedLine Citation:
|
PMID: 1237111 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Pyridostigmine-carbon 14 (P-C14) excretion studies in myasthenia gravis patients who had had thymectomies failed to produce any significant difference from results observed in myasthenic patients who had not had thymectomies. Thus, change in P-C14 metabolism cannot help explain decreased anticholinesterase requirements and electromyographic changes observed in some patients following thymectomy. |
| | |
Authors:
|
P Kornfeld; T N Mittag; G Genkins; S Horowitz; A E Papatestas |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Neurology Volume: 25 ISSN: 0028-3878 ISO Abbreviation: Neurology Publication Date: 1975 Oct |
Date Detail:
|
Created Date: 1975-12-23 Completed Date: 1975-12-23 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0401060 Medline TA: Neurology Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 998-9 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Female Humans Male Middle Aged Myasthenia Gravis / metabolism, surgery* Pyridostigmine Bromide / metabolism* Thymectomy* |
| Chemical | |
Reg. No./Substance:
|
101-26-8/Pyridostigmine Bromide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Subacute combined degeneration of the spinal cord with cystinuria.
Next Document: Suppression of expulsion of Aspiculuris tetraptera in hydrocortisone and methotrexate treated mice.